97
Mainz Biomed increases sales in 2023 from $0.53 million to $0.9 million. Operating expenses increased from $26.6 million to $27.1 million. The operating loss increased from $26.4 million to $26.6 million. The bottom line is that there is a loss of $26.29 million (previous year: -$26.38 million). CEO Guido Baechler speaks of important ones
Read the full article now